Parabilis Medicines

US · PBLS #2366 by market cap Listed 2026

28.82 -0.04 -0.14%

Live - 5344 symbols - heartbeat 356s ago · 2026-10-08 06:04

Pre-market 28.91 +0.32%

After-hours 28.82 0.00%

Reader sentiment Are you bullish or bearish on PBLS?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)
TipRanks · 2026/9/17
BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $45
Market Newswire · 2026/9/17
Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD)
TipRanks · 2026/8/14
LifeSci Capital Maintains Parabilis Medicines(PBLS.US) With Buy Rating, Maintains Target Price $42
Market Newswire · 2026/8/14
Rating change
LifeSci Capital Initiates Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $42
Market Newswire · 2026/7/18
BofA Securities Maintains Parabilis Medicines(PBLS.US) With Buy Rating
Market Newswire · 2026/8/14
Rating change
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS)
TipRanks · 2026/8/15
Rating change
A Quick Look at Today's Ratings for Parabilis Medicines(PBLS.US), With a Forecast Between $40 to $45
Market Newswire · 2026/7/7
Rating change
Guggenheim Sticks to Its Buy Rating for Parabilis Medicines, Inc. (PBLS)
TipRanks · 2026/8/17
Rating change
Parabilis Medicines, Inc. (PBLS) Receives a Buy From LifeSci Capital
TipRanks · 2026/7/13
Rating change
Analysts Offer Insights on Healthcare Companies: Parabilis Medicines, Inc. (PBLS) and LENZ Therapeutics (LENZ)
TipRanks · 2026/7/6

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 06:04:39 · For reference only, not investment advice and not tailored to your situation.